According to Laboratorios Farmaceuticos Rovi's latest financial reports and stock price the company's current Operating Margin is 24.63%. At the end of 2023 the company had an Operating Margin of 26.57%.
Year | Operating Margin | Change |
---|---|---|
2023 | 26.57% | -15.78% |
2022 | 31.55% | 12.06% |
2021 | 28.15% | 62.9% |
2020 | 17.28% | 57.36% |
2019 | 10.98% | 99.65% |
2018 | 5.50% | -13.46% |
2017 | 6.36% | -39.55% |
2016 | 10.51% | 23.78% |
2015 | 8.49% | -21.11% |
2014 | 10.77% | -3.38% |
2013 | 11.15% | 8% |
2012 | 10.32% | 0.7% |
2011 | 10.25% | -37.28% |
2010 | 16.34% | -5.16% |
2009 | 17.23% | -20.56% |
2008 | 21.69% | 9.98% |
2007 | 19.72% | 265.32% |
2006 | 5.40% | -60.08% |
2005 | 13.52% | -42.57% |
2004 | 23.54% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.